607 Impact of anifrolumab on neuropsychiatric manifestations of depression and suicidality in patients with systemic lupus erythematosus von Manzi, Susan, Lindholm, Catharina, Hupka, Ihor, Shroff, Manish, Abreu, Gabriel, Werther, Shanti, Tummala, Raj

Volltext

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus von Kalunian, Kenneth C., Furie, Richard, Morand, Eric F., Bruce, Ian N., Manzi, Susan, Tanaka, Yoshiya, Winthrop, Kevin, Hupka, Ihor, Zhang, Lijin (Jinny), Werther, Shanti, Abreu, Gabriel, Hultquist, Micki, Tummala, Raj, Lindholm, Catharina, Al‐Mossawi, Hussein

Volltext

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined... von Yang, Wenying, Ersoy, Canan, Wang, Guixia, Ye, Shandong, Liu, Jun, Miao, Heng, Asirvatham, Arthur, Werther, Shanti, Kadu, Priti, Chow, Francis

Volltext

A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes... von Linjawi, Sultan, Lee, Byung-Wan, Tabak, Ömür, Lövdahl, Susanna, Werther, Shanti, Abusnana, Salahedeen

Volltext

A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes... von Linjawi, Sultan, Byung-Wan Lee, Tabak, Ömür, Lövdahl, Susanna, Werther, Shanti, Salahedeen Abusnana

Volltext bestellen